167 related articles for article (PubMed ID: 22895314)
1. Generic HIV drugs will widen US treatment net.
Maxmen A
Nature; 2012 Aug; 488(7411):267. PubMed ID: 22895314
[No Abstract] [Full Text] [Related]
2. Improved adherence expected with new HIV combo treatment.
Morrow T
Manag Care; 2012 Nov; 21(11):53-4. PubMed ID: 23236718
[No Abstract] [Full Text] [Related]
3. Prevention. Using PrEP cost-effective in high-risk MSM groups.
AIDS Policy Law; 2012 Jun; 27(7):1. PubMed ID: 22803211
[No Abstract] [Full Text] [Related]
4. Indian pressure group challenges company's right to patent AIDS drug.
Mudur G
BMJ; 2006 May; 332(7551):1176. PubMed ID: 16709987
[No Abstract] [Full Text] [Related]
5. Kenya says yes to generic ARVs but fails to win Global Fund cash.
Njoroge J
Bull World Health Organ; 2002; 80(7):608. PubMed ID: 12163933
[No Abstract] [Full Text] [Related]
6. Generic Truvada approved.
AIDS Patient Care STDS; 2009 May; 23(5):395. PubMed ID: 19422066
[No Abstract] [Full Text] [Related]
7. Is there a role for generic antiretroviral drugs in the United States?
Wormser GP; Lappas T
Expert Rev Anti Infect Ther; 2014 Aug; 12(8):897-9. PubMed ID: 24918192
[TBL] [Abstract][Full Text] [Related]
8. HIV/AIDS: Latin America & Caribbean. Brazil: ten years after.
Cohen J
Science; 2006 Jul; 313(5786):484-7. PubMed ID: 16873654
[No Abstract] [Full Text] [Related]
9. [The patent legislation in India fails the HIV/AIDS work].
Holen Ø
Tidsskr Nor Laegeforen; 2005 Oct; 125(19):2666-7. PubMed ID: 16215618
[No Abstract] [Full Text] [Related]
10. Access to essential medications for HIV/AIDS in South Africa.
Andrews S
S Afr Med J; 2001 May; 91(5):384-7. PubMed ID: 11455797
[No Abstract] [Full Text] [Related]
11. Global AIDS trial denied patients as US balks at generic drug use.
Check E
Nature; 2004 Sep; 431(7008):493. PubMed ID: 15457219
[No Abstract] [Full Text] [Related]
12. TRIPS post-2005 and access to new antiretroviral treatments in southern countries: issues and challenges.
Orsi F; D'Almeida C; Hasenclever L; Camara M; Tigre P; Coriat B
AIDS; 2007 Oct; 21(15):1997-2003. PubMed ID: 17885289
[No Abstract] [Full Text] [Related]
13. Advantages of low-cost generic tenofovir instead of D4T for first-line antiretroviral therapy in Burma: a 2-year experience.
Moore S; Myint MM; Galau NH
AIDS; 2010 Jun; 24(10):1606-7. PubMed ID: 20539097
[No Abstract] [Full Text] [Related]
14. European CHMP issues positive opinion for Atripla.
AIDS Patient Care STDS; 2007 Nov; 21(11):890. PubMed ID: 18338431
[No Abstract] [Full Text] [Related]
15. Low-cost generic drugs under the President's Emergency Plan for AIDS Relief drove down treatment cost; more are needed.
Venkatesh KK; Mayer KH; Carpenter CC
Health Aff (Millwood); 2012 Jul; 31(7):1429-38. PubMed ID: 22778332
[TBL] [Abstract][Full Text] [Related]
16. India: New patent law may restrict access to HIV/AIDS treatments.
Cruess G
HIV AIDS Policy Law Rev; 2005 Aug; 10(2):28-30. PubMed ID: 16365971
[TBL] [Abstract][Full Text] [Related]
17. Physicians say generic AIDS drugs don't threaten R&D.
AIDS Policy Law; 2002 Mar; 17(6):4. PubMed ID: 12004757
[No Abstract] [Full Text] [Related]
18. HIV clinics are halting enrolment of new patients as funding stalls, MSF warns.
Roehr B
BMJ; 2009 Jul; 339():b2966. PubMed ID: 19620230
[No Abstract] [Full Text] [Related]
19. World Trade Organization still threatens supply of affordable AIDS drugs.
Hagmann M
Bull World Health Organ; 2002; 80(9):762-3. PubMed ID: 12378300
[No Abstract] [Full Text] [Related]
20. Generic drugs battle moves from South Africa to Kenya.
Siringi S
Lancet; 2001 May; 357(9268):1600. PubMed ID: 11377665
[No Abstract] [Full Text] [Related]
[Next] [New Search]
